Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 54

1.

Real-time Visualization of Breast Carcinoma in Pathology Specimens From Patients Receiving Fluorescent Tumor-Marking Agent Tozuleristide.

Dintzis SM, Hansen S, Harrington KM, Tan LC, Miller DM, Ishak L, Parrish-Novak J, Kittle D, Perry J, Gombotz C, Fortney T, Porenta S, Hales L, Calhoun KE, Anderson BO, Javid SH, Byrd DR.

Arch Pathol Lab Med. 2018 Dec 14. doi: 10.5858/arpa.2018-0197-OA. [Epub ahead of print]

PMID:
30550350
2.

NCCN Guidelines Insights: Thyroid Carcinoma, Version 2.2018.

Haddad RI, Nasr C, Bischoff L, Busaidy NL, Byrd D, Callender G, Dickson P, Duh QY, Ehya H, Goldner W, Haymart M, Hoh C, Hunt JP, Iagaru A, Kandeel F, Kopp P, Lamonica DM, McIver B, Raeburn CD, Ridge JA, Ringel MD, Scheri RP, Shah JP, Sippel R, Smallridge RC, Sturgeon C, Wang TN, Wirth LJ, Wong RJ, Johnson-Chilla A, Hoffmann KG, Gurski LA.

J Natl Compr Canc Netw. 2018 Dec;16(12):1429-1440. doi: 10.6004/jnccn.2018.0089.

PMID:
30545990
3.

Intratumoral G100, a TLR4 Agonist, Induces Antitumor Immune Responses and Tumor Regression in Patients with Merkel Cell Carcinoma.

Bhatia S, Miller NJ, Lu H, Longino NV, Ibrani D, Shinohara MM, Byrd DR, Parvathaneni U, Kulikauskas R, Ter Meulen J, Hsu FJ, Koelle DM, Nghiem P.

Clin Cancer Res. 2019 Feb 15;25(4):1185-1195. doi: 10.1158/1078-0432.CCR-18-0469. Epub 2018 Aug 9.

PMID:
30093453
4.

Lymphedema symptoms and limb measurement changes in breast cancer survivors treated with neoadjuvant chemotherapy and axillary dissection: results of American College of Surgeons Oncology Group (ACOSOG) Z1071 (Alliance) substudy.

Armer JM, Ballman KV, McCall L, Armer NC, Sun Y, Udmuangpia T, Hunt KK, Mittendorf EA, Byrd DR, Julian TB, Boughey JC.

Support Care Cancer. 2019 Feb;27(2):495-503. doi: 10.1007/s00520-018-4334-7. Epub 2018 Jul 6.

PMID:
29980907
5.

Melanoma staging: Evidence-based changes in the American Joint Committee on Cancer eighth edition cancer staging manual.

Gershenwald JE, Scolyer RA, Hess KR, Sondak VK, Long GV, Ross MI, Lazar AJ, Faries MB, Kirkwood JM, McArthur GA, Haydu LE, Eggermont AMM, Flaherty KT, Balch CM, Thompson JF; for members of the American Joint Committee on Cancer Melanoma Expert Panel and the International Melanoma Database and Discovery Platform.

CA Cancer J Clin. 2017 Nov;67(6):472-492. doi: 10.3322/caac.21409. Epub 2017 Oct 13.

6.

Long-Term Survival after Complete Surgical Resection and Adjuvant Immunotherapy for Distant Melanoma Metastases.

Faries MB, Mozzillo N, Kashani-Sabet M, Thompson JF, Kelley MC, DeConti RC, Lee JE, Huth JF, Wagner J, Dalgleish A, Pertschuk D, Nardo C, Stern S, Elashoff R, Gammon G, Morton DL; MMAIT-IV Clinical Trial Group.

Ann Surg Oncol. 2017 Dec;24(13):3991-4000. doi: 10.1245/s10434-017-6072-3. Epub 2017 Oct 10.

PMID:
29019177
7.

The Eighth Edition of TNM: Implications for the Surgical Oncologist.

Byrd DR, Greene FL.

Ann Surg Oncol. 2018 Jan;25(1):10-12. doi: 10.1245/s10434-017-6027-8. Epub 2017 Aug 7. No abstract available.

PMID:
28785899
8.

The TNM classification of malignant tumours-towards common understanding and reasonable expectations.

O'Sullivan B, Brierley J, Byrd D, Bosman F, Kehoe S, Kossary C, Piñeros M, Van Eycken E, Weir HK, Gospodarowicz M.

Lancet Oncol. 2017 Jul;18(7):849-851. doi: 10.1016/S1470-2045(17)30438-2. No abstract available.

9.

Tumor Biology and Response to Chemotherapy Impact Breast Cancer-specific Survival in Node-positive Breast Cancer Patients Treated With Neoadjuvant Chemotherapy: Long-term Follow-up From ACOSOG Z1071 (Alliance).

Boughey JC, Ballman KV, McCall LM, Mittendorf EA, Symmans WF, Julian TB, Byrd D, Hunt KK.

Ann Surg. 2017 Oct;266(4):667-676. doi: 10.1097/SLA.0000000000002373.

10.

Completion Dissection or Observation for Sentinel-Node Metastasis in Melanoma.

Faries MB, Thompson JF, Cochran AJ, Andtbacka RH, Mozzillo N, Zager JS, Jahkola T, Bowles TL, Testori A, Beitsch PD, Hoekstra HJ, Moncrieff M, Ingvar C, Wouters MWJM, Sabel MS, Levine EA, Agnese D, Henderson M, Dummer R, Rossi CR, Neves RI, Trocha SD, Wright F, Byrd DR, Matter M, Hsueh E, MacKenzie-Ross A, Johnson DB, Terheyden P, Berger AC, Huston TL, Wayne JD, Smithers BM, Neuman HB, Schneebaum S, Gershenwald JE, Ariyan CE, Desai DC, Jacobs L, McMasters KM, Gesierich A, Hersey P, Bines SD, Kane JM, Barth RJ, McKinnon G, Farma JM, Schultz E, Vidal-Sicart S, Hoefer RA, Lewis JM, Scheri R, Kelley MC, Nieweg OE, Noyes RD, Hoon DSB, Wang HJ, Elashoff DA, Elashoff RM.

N Engl J Med. 2017 Jun 8;376(23):2211-2222. doi: 10.1056/NEJMoa1613210.

11.

The Eighth Edition AJCC Cancer Staging Manual: Continuing to build a bridge from a population-based to a more "personalized" approach to cancer staging.

Amin MB, Greene FL, Edge SB, Compton CC, Gershenwald JE, Brookland RK, Meyer L, Gress DM, Byrd DR, Winchester DP.

CA Cancer J Clin. 2017 Mar;67(2):93-99. doi: 10.3322/caac.21388. Epub 2017 Jan 17.

12.

Why Thyroid Surgeons Are Frustrated with Radiologists: Lessons Learned from Pre- and Postoperative US.

Kumbhar SS, O'Malley RB, Robinson TJ, Maximin S, Lalwani N, Byrd DR, Wang CL.

Radiographics. 2016 Nov-Dec;36(7):2141-2153. Epub 2016 Oct 21. Review.

PMID:
27768542
13.

Adjuvant Radiation Therapy and Chemotherapy in Merkel Cell Carcinoma: Survival Analyses of 6908 Cases From the National Cancer Data Base.

Bhatia S, Storer BE, Iyer JG, Moshiri A, Parvathaneni U, Byrd D, Sober AJ, Sondak VK, Gershenwald JE, Nghiem P.

J Natl Cancer Inst. 2016 May 31;108(9). pii: djw042. doi: 10.1093/jnci/djw042. Print 2016 Sep.

14.

Anaplastic Thyroid Carcinoma, Version 2.2015.

Haddad RI, Lydiatt WM, Ball DW, Busaidy NL, Byrd D, Callender G, Dickson P, Duh QY, Ehya H, Haymart M, Hoh C, Hunt JP, Iagaru A, Kandeel F, Kopp P, Lamonica DM, McCaffrey JC, Moley JF, Parks L, Raeburn CD, Ridge JA, Ringel MD, Scheri RP, Shah JP, Smallridge RC, Sturgeon C, Wang TN, Wirth LJ, Hoffmann KG, Hughes M.

J Natl Compr Canc Netw. 2015 Sep;13(9):1140-50.

15.

Thyroid carcinoma, version 2.2014.

Tuttle RM, Haddad RI, Ball DW, Byrd D, Dickson P, Duh QY, Ehya H, Haymart M, Hoh C, Hunt JP, Iagaru A, Kandeel F, Kopp P, Lamonica DM, Lydiatt WM, McCaffrey J, Moley JF, Parks L, Raeburn CD, Ridge JA, Ringel MD, Scheri RP, Shah JP, Sherman SI, Sturgeon C, Waguespack SG, Wang TN, Wirth LJ, Hoffmann KG, Hughes M.

J Natl Compr Canc Netw. 2014 Dec;12(12):1671-80; quiz 1680.

PMID:
25505208
16.

Different effects of valproic acid on photoreceptor loss in Rd1 and Rd10 retinal degeneration mice.

Mitton KP, Guzman AE, Deshpande M, Byrd D, DeLooff C, Mkoyan K, Zlojutro P, Wallace A, Metcalf B, Laux K, Sotzen J, Tran T.

Mol Vis. 2014 Nov 4;20:1527-44. eCollection 2014.

17.

Age as a predictor of sentinel node metastasis among patients with localized melanoma: an inverse correlation of melanoma mortality and incidence of sentinel node metastasis among young and old patients.

Balch CM, Thompson JF, Gershenwald JE, Soong SJ, Ding S, McMasters KM, Coit DG, Eggermont AM, Gimotty PA, Johnson TM, Kirkwood JM, Leong SP, Ross MI, Byrd DR, Cochran AJ, Mihm MC Jr, Morton DL, Atkins MB, Flaherty KT, Sondak VK.

Ann Surg Oncol. 2014 Apr;21(4):1075-81. doi: 10.1245/s10434-013-3464-x. Epub 2014 Feb 15.

18.

Relationships among primary tumor size, number of involved nodes, and survival for 8044 cases of Merkel cell carcinoma.

Iyer JG, Storer BE, Paulson KG, Lemos B, Phillips JL, Bichakjian CK, Zeitouni N, Gershenwald JE, Sondak V, Otley CC, Yu SS, Johnson TM, Liegeois NJ, Byrd D, Sober A, Nghiem P.

J Am Acad Dermatol. 2014 Apr;70(4):637-643. doi: 10.1016/j.jaad.2013.11.031. Epub 2014 Feb 9.

19.

Sentinel lymph node surgery after neoadjuvant chemotherapy in patients with node-positive breast cancer: the ACOSOG Z1071 (Alliance) clinical trial.

Boughey JC, Suman VJ, Mittendorf EA, Ahrendt GM, Wilke LG, Taback B, Leitch AM, Kuerer HM, Bowling M, Flippo-Morton TS, Byrd DR, Ollila DW, Julian TB, McLaughlin SA, McCall L, Symmans WF, Le-Petross HT, Haffty BG, Buchholz TA, Nelson H, Hunt KK; Alliance for Clinical Trials in Oncology.

JAMA. 2013 Oct 9;310(14):1455-61. doi: 10.1001/jama.2013.278932.

20.

Pathologic nodal evaluation is increasingly commonly performed for patients with Merkel cell carcinoma.

Paulson KG, Iyer JG, Byrd DR, Nghiem P.

J Am Acad Dermatol. 2013 Oct;69(4):653-4. doi: 10.1016/j.jaad.2013.06.002. No abstract available.

21.

Combining safety and trainee education in surgical oncology: we all win.

Byrd DR.

Ann Surg Oncol. 2013 Nov;20(12):3705-6. doi: 10.1245/s10434-013-3081-8. No abstract available.

PMID:
24006093
22.

Contaminated ventilator air flow sensor linked to Bacillus cereus colonization of newborns.

Turabelidze G, Gee JE, Hoffmaster AR, Manian F, Butler C, Byrd D, Schildknecht S, Hauser LC, Duncan M, Ferrett R, Evans D, Talley C.

Emerg Infect Dis. 2013 May;19(5):781-3. doi: 10.3201/eid1905.12039.

23.

Unilateral vs bilateral parathyroidectomy: a healthy debate.

Stojadinovic A, Pribitkin E, Rosen D, Edwards M, Byrd DR.

J Am Coll Surg. 2012 Aug;215(2):300-2. doi: 10.1016/j.jamcollsurg.2012.04.025. No abstract available.

PMID:
22818102
24.

BRCA testing is important for our patients.

Anderson BO, Javid SH, Calhoun KE, Byrd DR.

Surgery. 2012 Apr;151(4):637-8. doi: 10.1016/j.surg.2011.12.031. Epub 2012 Feb 4. No abstract available.

PMID:
22306834
25.

Merkel cell polyomavirus-specific CD8⁺ and CD4⁺ T-cell responses identified in Merkel cell carcinomas and blood.

Iyer JG, Afanasiev OK, McClurkan C, Paulson K, Nagase K, Jing L, Marshak JO, Dong L, Carter J, Lai I, Farrar E, Byrd D, Galloway D, Yee C, Koelle DM, Nghiem P.

Clin Cancer Res. 2011 Nov 1;17(21):6671-80. doi: 10.1158/1078-0432.CCR-11-1513. Epub 2011 Sep 9.

26.

Identification and validation of a novel mature microRNA encoded by the Merkel cell polyomavirus in human Merkel cell carcinomas.

Lee S, Paulson KG, Murchison EP, Afanasiev OK, Alkan C, Leonard JH, Byrd DR, Hannon GJ, Nghiem P.

J Clin Virol. 2011 Nov;52(3):272-5. doi: 10.1016/j.jcv.2011.08.012. Epub 2011 Sep 9.

27.

Pregnancy after breast cancer: if you wish, ma'am.

Pagani O, Partridge A, Korde L, Badve S, Bartlett J, Albain K, Gelber R, Goldhirsch A; Breast International Group; North American Breast Cancer Group Endocrine Working Group.

Breast Cancer Res Treat. 2011 Sep;129(2):309-17. doi: 10.1007/s10549-011-1643-7. Epub 2011 Jun 23. Review.

PMID:
21698406
28.

Prognostic significance of mitotic rate in localized primary cutaneous melanoma: an analysis of patients in the multi-institutional American Joint Committee on Cancer melanoma staging database.

Thompson JF, Soong SJ, Balch CM, Gershenwald JE, Ding S, Coit DG, Flaherty KT, Gimotty PA, Johnson T, Johnson MM, Leong SP, Ross MI, Byrd DR, Cascinelli N, Cochran AJ, Eggermont AM, McMasters KM, Mihm MC Jr, Morton DL, Sondak VK.

J Clin Oncol. 2011 Jun 1;29(16):2199-205. doi: 10.1200/JCO.2010.31.5812. Epub 2011 Apr 25. Erratum in: J Clin Oncol. 2011 Jul 20;29(21):2949.

29.

Transcriptome-wide studies of merkel cell carcinoma and validation of intratumoral CD8+ lymphocyte invasion as an independent predictor of survival.

Paulson KG, Iyer JG, Tegeder AR, Thibodeau R, Schelter J, Koba S, Schrama D, Simonson WT, Lemos BD, Byrd DR, Koelle DM, Galloway DA, Leonard JH, Madeleine MM, Argenyi ZB, Disis ML, Becker JC, Cleary MA, Nghiem P.

J Clin Oncol. 2011 Apr 20;29(12):1539-46. doi: 10.1200/JCO.2010.30.6308. Epub 2011 Mar 21.

30.

A new American Joint Committee on Cancer staging system for cutaneous squamous cell carcinoma: creation and rationale for inclusion of tumor (T) characteristics.

Farasat S, Yu SS, Neel VA, Nehal KS, Lardaro T, Mihm MC, Byrd DR, Balch CM, Califano JA, Chuang AY, Sharfman WH, Shah JP, Nghiem P, Otley CC, Tufaro AP, Johnson TM, Sober AJ, Liégeois NJ.

J Am Acad Dermatol. 2011 Jun;64(6):1051-9. doi: 10.1016/j.jaad.2010.08.033. Epub 2011 Jan 20.

31.

Thyroid carcinoma.

Tuttle RM, Ball DW, Byrd D, Dilawari RA, Doherty GM, Duh QY, Ehya H, Farrar WB, Haddad RI, Kandeel F, Kloos RT, Kopp P, Lamonica DM, Loree TR, Lydiatt WM, McCaffrey JC, Olson JA Jr, Parks L, Ridge JA, Shah JP, Sherman SI, Sturgeon C, Waguespack SG, Wang TN, Wirth LJ; National Comprehensive Cancer Network.

J Natl Compr Canc Netw. 2010 Nov;8(11):1228-74. No abstract available.

PMID:
21081783
32.

Pathologic nodal evaluation improves prognostic accuracy in Merkel cell carcinoma: analysis of 5823 cases as the basis of the first consensus staging system.

Lemos BD, Storer BE, Iyer JG, Phillips JL, Bichakjian CK, Fang LC, Johnson TM, Liegeois-Kwon NJ, Otley CC, Paulson KG, Ross MI, Yu SS, Zeitouni NC, Byrd DR, Sondak VK, Gershenwald JE, Sober AJ, Nghiem P.

J Am Acad Dermatol. 2010 Nov;63(5):751-61. doi: 10.1016/j.jaad.2010.02.056. Epub 2010 Jun 19.

33.

Medullary carcinoma.

Tuttle RM, Ball DW, Byrd D, Daniels GH, Dilawari RA, Doherty GM, Duh QY, Ehya H, Farrar WB, Haddad RI, Kandeel F, Kloos RT, Kopp P, Lamonica DM, Loree TR, Lydiatt WM, McCaffrey J, Olson JA Jr, Parks L, Ridge JA, Shah JP, Sherman SI, Sturgeon C, Waguespack SG, Wang TN, Wirth LJ; National Comprehensive Cancer Network.

J Natl Compr Canc Netw. 2010 May;8(5):512-30. No abstract available.

PMID:
20495082
34.

Predicting survival outcome of localized melanoma: an electronic prediction tool based on the AJCC Melanoma Database.

Soong SJ, Ding S, Coit D, Balch CM, Gershenwald JE, Thompson JF, Gimotty P; AJCC Melanoma Task Force.

Ann Surg Oncol. 2010 Aug;17(8):2006-14. doi: 10.1245/s10434-010-1050-z. Epub 2010 Apr 9.

PMID:
20379784
35.

Multivariate analysis of prognostic factors among 2,313 patients with stage III melanoma: comparison of nodal micrometastases versus macrometastases.

Balch CM, Gershenwald JE, Soong SJ, Thompson JF, Ding S, Byrd DR, Cascinelli N, Cochran AJ, Coit DG, Eggermont AM, Johnson T, Kirkwood JM, Leong SP, McMasters KM, Mihm MC Jr, Morton DL, Ross MI, Sondak VK.

J Clin Oncol. 2010 May 10;28(14):2452-9. doi: 10.1200/JCO.2009.27.1627. Epub 2010 Apr 5.

36.

The persistent anchor of lymph node removal in patients with melanoma.

Byrd DR.

Cancer. 2010 Mar 1;116(5):1150-2. doi: 10.1002/cncr.24869. No abstract available.

37.

Preoperative and intraoperative sonographic visibility of collagen-based breast biopsy marker clips.

Eby PR, Calhoun KE, Kurland BF, Demartini WB, Gutierrez RL, Peacock S, Anderson BO, Byrd DR, Mann GN, Lehman CD.

Acad Radiol. 2010 Mar;17(3):340-7. doi: 10.1016/j.acra.2009.10.017. Epub 2009 Dec 30.

PMID:
20042350
38.

Final version of 2009 AJCC melanoma staging and classification.

Balch CM, Gershenwald JE, Soong SJ, Thompson JF, Atkins MB, Byrd DR, Buzaid AC, Cochran AJ, Coit DG, Ding S, Eggermont AM, Flaherty KT, Gimotty PA, Kirkwood JM, McMasters KM, Mihm MC Jr, Morton DL, Ross MI, Sober AJ, Sondak VK.

J Clin Oncol. 2009 Dec 20;27(36):6199-206. doi: 10.1200/JCO.2009.23.4799. Epub 2009 Nov 16.

39.

NCCN Clinical Practice Guidelines in Oncology: neuroendocrine tumors.

Clark OH, Benson AB 3rd, Berlin JD, Choti MA, Doherty GM, Engstrom PF, Gibbs JF, Heslin MJ, Kessinger A, Kulke MH, Kvols L, Salem R, Saltz L, Shah MH, Shibata S, Strosberg JR, Yao JC; NCCN Neuroendocrine Tumors Panel Members.

J Natl Compr Canc Netw. 2009 Jul;7(7):712-47. No abstract available.

PMID:
19635226
40.

Head and neck malignant melanoma: margin status and immediate reconstruction.

Sullivan SR, Scott JR, Cole JK, Chi Y, Anaya DA, Byrd DR, Yeung RS, Mann GN, Isik FF.

Ann Plast Surg. 2009 Feb;62(2):144-8. doi: 10.1097/SAP.0b013e31817dadc8.

PMID:
19158523
41.

Pulsed radiofrequency for chronic pain.

Byrd D, Mackey S.

Curr Pain Headache Rep. 2008 Jan;12(1):37-41. Review.

42.

Locally advanced and inflammatory breast cancer.

Chia S, Swain SM, Byrd DR, Mankoff DA.

J Clin Oncol. 2008 Feb 10;26(5):786-90. doi: 10.1200/JCO.2008.15.0243. Review. No abstract available.

PMID:
18258987
43.

Thyroid carcinoma.

Sherman SI, Angelos P, Ball DW, Byrd D, Clark OH, Daniels GH, Dilawari RA, Ehya H, Farrar WB, Gagel RF, Kandeel F, Kloos RT, Kopp P, Lamonica DM, Loree TR, Lydiatt WM, McCaffrey J, Olson JA Jr, Ridge JA, Shah JP, Sisson JC, Tuttle RM, Urist MM; National Comprehensive Cancer Network Thyroid Carcinoma Panel.

J Natl Compr Canc Netw. 2007 Jul;5(6):568-621. No abstract available.

PMID:
17623612
44.

Internal mammary nodal chain drainage is a prognostic indicator in axillary node-positive breast cancer.

Yao MS, Kurland BF, Smith AH, Schubert EK, Dunnwald LK, Byrd DR, Mankoff DA.

Ann Surg Oncol. 2007 Oct;14(10):2985-93. Epub 2007 Jun 13.

PMID:
17564747
45.

Brief report: sentinel lymph node dissection and burn scar carcinoma sentinel node and burn scar carcinoma.

Cobey FC, Engrav LH, Klein MB, Isom CN, Byrd DR.

Burns. 2008 Mar;34(2):271-4. Epub 2007 Mar 19. No abstract available.

PMID:
17374455
46.

Medullary thyroid cancer: options for systemic therapy of metastatic disease?

Martins RG, Rajendran JG, Capell P, Byrd DR, Mankoff DA.

J Clin Oncol. 2006 Apr 10;24(11):1653-5. Epub 2006 Mar 20. No abstract available.

PMID:
16549818
47.

Neuroendocrine tumors.

Clark OH, Ajani J, Benson AB 3rd, Byrd D, Doherty GM, Engstrom PF, Ettinger DS, Gibbs JF, Heslin MJ, Kandeel F, Kessinger A, Kulke MH, Kvols L, Nemcek AA Jr, Olson JA Jr, Ratliff TW, Saltz L, Schteingart DE, Shah MH, Shibata S; National Comprehensive Cancer Network.

J Natl Compr Canc Netw. 2006 Feb;4(2):102-38. Review. No abstract available.

PMID:
16451769
48.

[11C]metahydroxyephedrine and [18F]fluorodeoxyglucose positron emission tomography improve clinical decision making in suspected pheochromocytoma.

Mann GN, Link JM, Pham P, Pickett CA, Byrd DR, Kinahan PE, Krohn KA, Mankoff DA.

Ann Surg Oncol. 2006 Feb;13(2):187-97. Epub 2006 Jan 19.

PMID:
16418883
49.

Thyroid carcinoma.

Sherman SI, Angelos P, Ball DW, Beenken SW, Byrd D, Clark OH, Daniels GH, Dilawari RA, Ehya H, Farrar WB, Gagel RF, Kandeel F, Kloos RT, Kopp P, Lamonica DM, Loree TR, Lydiatt WM, McCaffrey J, Olson JA Jr, Ridge JA, Robbins R, Shah JP, Sisson JC, Thompson NW; National Comprehensive Cancer Network.

J Natl Compr Canc Netw. 2005 May;3(3):404-57. No abstract available.

PMID:
16002006
50.

A new indication for pancreas transplantation: high grade pancreatic dysplasia.

Charpentier KP, Brentnall TA, Bronner MP, Byrd D, Marsh C.

Clin Transplant. 2004 Feb;18(1):105-7.

PMID:
15108779

Supplemental Content

Loading ...
Support Center